Ó£»¨ÊÓƵ

Skip to main content

Table 1 Characteristics of participants, stratified by COVID-19 vaccination status and vaccine hesitancy

From: Uptake and hesitancy of the second booster dose of COVID-19 vaccine among the general population in China after the surge period of the COVID-19 pandemic: a large-scale national study

variables

Total N = 10,164

vaccinated at least one dose (N = 10,034)

Unvaccinated (N = 130)

willing to vaccinate (N = 5,700)

hesitant to vaccinate (N = 4,334)

willing to vaccinate (N = 32)

hesitant to vaccinate (N = 98)

Gender

 M²¹±ô±ð

3,273

1,873

1,359

11

30

(32.2%)

(58.0%)

(42.0%)

(26.8%)

(73.2%)

 F±ð³¾²¹±ô±ð

6,891

3,827

2,975

21

68

(67.8%)

(56.3%)

(43.7%)

(23.6%)

(76.4%)

Age, mean ± SD

29.09 ±â¶Ä‰12.59

28.70 ±â¶Ä‰12.74

29.42 ±â¶Ä‰12.27

35.84 ±â¶Ä‰15.35

34.94 ±â¶Ä‰14.22

Age

 18–59

9,902

5,529

4,253

28

92

(97.4%)

(56.5%)

(43.5%)

(23.3%)

(76.7%)

 60 and above

262

171

81

4

6

(2.6%)

(67.9%)

(32.1%)

(40.0%)

(60.0%)

Region

 C±ð²Ô³Ù°ù²¹±ô

1,712

918

767

7

20

(16.8%)

(54.5%)

(45.5%)

(25.9%)

(74.1%)

 N´Ç°ù³Ù³ó

3,991

2,323

1,636

8

24

(39.3%)

(58.7%)

(41.3%)

(25.0%)

(75.0%)

 E²¹²õ³Ù

387

210

167

0

10

(3.8%)

(55.7%)

(44.3%)

(0.0%)

(100.0%)

â€Çȴdzܳٳó

1,371

836

521

3

11

(13.5%)

(61.6%)

(38.4%)

(21.4%)

(78.6%)

 W±ð²õ³Ù

2,703

1,413

1,243

14

33

(26.6%)

(53.2%)

(46.8%)

(29.8%)

(70.2%)

Education level

 Primary school and below

110

64

41

2

3

(1.1%)

(61.0%)

(39.0%)

(40.0%)

(60.0%)

 Junior high school

376

212

161

0

3

(3.7%)

(56.8%)

(43.2%)

(0.0%)

(100.0%)

 Senior high school

926

483

432

3

8

(9.1%)

(52.8%)

(47.2%)

(27.3%)

(72.7%)

 University or college

7,550

4,287

3,178

22

63

(74.3%)

(57.4%)

(42.6%)

(25.9%)

(74.1%)

 Graduate degree

1,202

654

522

5

21

(11.8%)

(55.6%)

(44.4%)

(19.2%)

(80.8%)

Student status

 N´Ç

4,818

2,489

2,231

24

74

(47.4%)

(52.7%)

(47.3%)

(24.5%)

(75.5%)

 Y±ð²õ

5,346

3,211

2,103

8

24

(52.6%)

(60.4%)

(39.6%)

(25.0%)

(75.0%)

Monthly income (CNY)

 &±ô³Ù; 5,000

7,298

4,212

3,020

16

50

(71.8%)

(58.2%)

(41.8%)

(24.2%)

(75.8%)

 5,000–9,999

2,074

1,105

930

9

30

(20.4%)

(54.3%)

(45.7%)

(23.1%)

(76.9%)

 10,000–29,999

629

309

303

5

12

(6.2%)

(50.5%)

(49.5%)

(29.4%)

(70.6%)

 ≥ 30,000

163

74

81

2

6

(1.6%)

(47.7%)

(52.3%)

(25.0%)

(75.0%)

Cohabitation status

â€Çã±ô´Ç²Ô±ð

717

383

320

2

12

(7.1%)

(54.5%)

(45.5%)

(14.3%)

(85.7%)

 C´Ç³ó²¹²ú¾±³Ù²¹³Ù¾±´Ç²Ô

9,447

5,317

4,014

30

86

(92.9%)

(57.0%)

(43.0%)

(25.9%)

(74.1%)

Chronic disease

 N´Ç

9,231

5,226

3,905

26

74

(90.8%)

(57.2%)

(42.8%)

(26.0%)

(74.0%)

 Y±ð²õ

933

474

429

6

24

(9.2%)

(52.5%)

(47.5%)

(20.0%)

(80.0%)

Covid-19 infection status

 U²Ô¾±²Ô´Ú±ð³¦³Ù±ð»å

1,464

886

550

7

21

(14.4%)

(61.7%)

(38.3%)

(25.0%)

(75.0%)

 During infection

449

207

232

1

9

(4.4%)

(47.2%)

(52.8%)

(10.0%)

(90.0%)

 R±ð³¦´Ç±¹±ð°ù±ð»å

7,070

3,973

3,018

19

60

(69.6%)

(56.8%)

(43.2%)

(24.1%)

(75.9%)

 U²Ô°ì²Ô´Ç·É²Ô

1,181

634

534

5

8

(11.6%)

(54.3%)

(45.7%)

(38.5%)

(61.5%)

Depressive symptoms

 M¾±²Ô¾±³¾²¹±ô

3,931

2,514

1,367

16

34

(38.7%)

(64.8%)

(35.2%)

(32.0%)

(68.0%)

 M¾±±ô»å

3,583

1,977

1,568

11

27

(35.2%)

(55.8%)

(44.2%)

(28.9%)

(71.1%)

 M´Ç»å±ð°ù²¹³Ù±ð

1,372

660

693

2

17

(13.5%)

(48.8%)

(51.2%)

(10.5%)

(89.5%)

â€Çȱ𱹱ð°ù±ð

1,278

549

706

3

20

(12.6%)

(43.7%)

(56.3%)

(13.0%)

(87.0%)

Anxiety symptoms

 M¾±²Ô¾±³¾²¹±ô

6,006

3,684

2,251

21

50

(59.1%)

(62.1%)

(37.9%)

(29.6%)

(70.4%)

 M¾±±ô»å

2,701

1,367

1,301

10

23

(26.6%)

(51.2%)

(48.8%)

(30.3%)

(69.7%)

 M´Ç»å±ð°ù²¹³Ù±ð

1,000

444

539

1

16

(9.8%)

(45.2%)

(54.8%)

(5.9%)

(94.1%)

â€Çȱ𱹱ð°ù±ð

457

205

243

0

9

(4.5%)

(45.8%)

(54.2%)

(0.0%)

(100.0%)

PTSD symptoms

 N´Ç

6,637

3,975

2,585

22

55

(65.3%)

(60.6%)

(39.4%)

(28.6%)

(71.4%)

 Y±ð²õ

3,527

1,725

1,749

10

43

(34.7%)

(49.7%)

(50.3%)

(18.9%)

(81.1%)

Have received other vaccines in the past five years

 N´Ç

7,747

4,325

3,319

26

77

(76.2%)

(56.6%)

(43.4%)

(25.2%)

(74.8%)

 Y±ð²õ

2,417

1,375

1,015

6

21

(23.8%)

(57.5%)

(42.5%)

(22.2%)

(77.8%)

Have experienced adverse reactions after COVID-19 vaccination

 N´Ç

—

4,203

2,757

—

(60.4%)

(39.6%)

 Y±ð²õ

1,497

1,577

(48.7%)

(51.3%)

Social Support, mean ± SD

14.55 ±â¶Ä‰4.85

15.91 ±â¶Ä‰4.13

12.8 ±â¶Ä‰5.11

15.22 ±â¶Ä‰5.19

12.58 ±â¶Ä‰6.00